Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A man with myotonic dystrophy type 1 had 28 skin cancers, suggesting a link between the disease and skin cancer, emphasizing the need for sun protection and regular skin checks.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

A girl with skin rashes and low zinc levels improved with zinc supplements and had new gene mutations linked to her condition.

Rabbits lacking the Hoxc13 gene show similar hair and skin issues to humans with ECTD-9, making them good for research on this condition.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

A pathway helps maintain long telomeres in both stem and cancer cells.

Mutations in the androgen receptor gene cause different levels of androgen insensitivity, making it hard to create simple tests for the condition.

CDH3-related disease causes worsening eye and hair issues.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

FOXN1 duplication can cause excessive hair growth.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

A patient with Werner syndrome showed a range of aging-like symptoms and metabolic issues, underscoring the need for early detection and treatment.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Lgr5 and the vitamin D receptor are key in controlling skin inflammation and tumor risk in mice.

Tofacitinib is a promising treatment for children with rheumatic diseases.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Efficient enzyme function relies on specific residue interactions and structural coordination.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

The keratin 5 mutation in a family with epidermolysis bullosa simplex was due to mosaicism, not a new mutation.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Progerin affects cell shape but not hair or skin in mice.

Certain gene variants can influence acne risk and severity.

A rare gene mutation causes skin fragility and itching without affecting hair or nails.

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Certain genetic variations can make people more likely to experience hair loss and low white blood cell count from azathioprine.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

A virus protein can activate a pathway that may lead to abnormal hair follicle development.